The share price of Biocept, Inc. [NASDAQ: BIOC] inclined by $0.32, presently trading at $0.32. The company’s shares saw 41.49% gains compared to the lowest price in the period of the last 52 weeks, set at $0.23 recorded on 02/13/20. The last few days have been benevolent to the share price as BIOC fall by -4.00% during the last week, even though the stock is still down by -10.67% compared to -0.01 of all time high it touched on 02/10/20. However, the stock had a poor performance during the past 3 months, roughly losing -5.82%, while additionally dropping -69.21% during the last 12 months. Biocept, Inc. is said to have a 12-month price target set at $1.00. That means that the stock has a strong potential to acquire 0.68% increase from the current trading price.
Biocept, Inc. [NASDAQ:BIOC]: Analyst Rating and Earnings
Its stock price has been found in the range of 0.23 to 2.11. This is compared to its latest closing price of $0.32.
Biocentral
47m
$BIOC We are very pleased to make our Target Selector™ platform available for testing CSF, as a more rapid identification of molecular alterations in brain metastases can aid physicians in choosing the best treatment options for their patients with breast or lung cancer," said Michael W. Nall, Biocept's President and CEO. "Among the significant capabilities of our technology is its versatility, which enables applications in a variety of clinical situations and for use with multiple types of biofluids."
EMPM- train about to leave the station for Nasdaq. SAEAN EV Industries
Market Data 
Markets 
AI
